A federal court recently ruled to approve Lunai Bioworks' request for expedited discovery.

This decision will enable the company to swiftly obtain relevant trading records, with the aim of identifying and confirming the traders suspected of engaging in “naked short selling” of its shares. “Naked short selling” refers to the act of selling short without actually borrowing the shares, and this practice is strictly regulated or even prohibited in most markets. Lunai Bioworks’ court-supported discovery process marks a significant step forward in its response to potential market manipulation. By accelerating the discovery procedures, the company is expected to collect evidence more quickly and clarify abnormal patterns in trading activity. This legal action reflects the increasing attention publicly listed companies are paying to, and their proactive response toward, market activities that may affect stock prices. As the discovery process progresses, further developments are likely to draw the close attention of market participants.